Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study

The Mexican influenza vaccination program does not include a recommendation for people aged 50–59 years without risk factors for influenza complications, and there are limited data regarding the cost-effectiveness of vaccinating this population. To explore the clinical and economic effects of includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Betancourt-Cravioto, Miguel, Falcón-Lezama, Jorge Abelardo, Saucedo-Martínez, Rodrigo, Alfaro-Cortés, Myrna María, Tapia-Conyer, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995959/
https://www.ncbi.nlm.nih.gov/pubmed/33668199
http://dx.doi.org/10.3390/vaccines9030188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995959/
https://www.ncbi.nlm.nih.gov/pubmed/33668199
http://dx.doi.org/10.3390/vaccines9030188

Ejemplares similares